We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Adaptate Biotherapeutics Formed To Develop T-cell Modulating Antibody-based Therapies

Product News   Oct 16, 2019

 
Adaptate Biotherapeutics Formed To Develop T-cell Modulating Antibody-based Therapies
FURTHER INFORMATION
 
 
 

Related Product News

Advances in Bavarian Nordic’s Cancer Immunotherapy Platform

Product News

A paper discussing recent preclinical advances of Bavarian Nordic’s novel cancer immunotherapy platform has been published in Nature Communications.

READ MORE

Combined Whole Transcriptome and Protein Analysis Solution for HD Immunology

Product News

BD has launched a combined whole transcriptome and protein analysis solution for HD immunology.

READ MORE

Advancing Cancer Therapy With Exosome Isolation and Detection Kits

Product News

AMSBIO have introduced a new range of reagents designed for researchers investigating targeted cancer therapy.

READ MORE

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE